Last updated: July 29, 2025
Introduction
Patent KR20170016985 pertains to innovative pharmaceutical technology filed in South Korea, with the title likely revolving around a novel drug composition or therapeutic method, given the pattern of patent document volumes in the country. A detailed examination of its scope, claims, and patent landscape offers vital insights into its strategic implications, competitive positioning, and innovation trajectory within the South Korean pharmaceutical patent ecosystem.
Patent Overview and Filing Context
Filed under the Korean Intellectual Property Office (KIPO), patent KR20170016985 was published in 2017, indicating an application likely submitted in 2016 or late 2015. South Korea’s patent system permits broad claims directed toward chemical compounds, biological agents, formulations, and therapeutic methods within pharmaceutical sciences.
Given the patent’s numbering and typical nomenclature, it implicates a unique chemical entity, novel formulation, or a therapeutic use thereof. The patent owner, often a major pharmaceutical company or biotechnology firm, seeks protection for specific innovations designed to address unmet medical needs, improve bioavailability, or minimize side effects.
Scope and Claims Analysis
Claim Structure and Focus
The claims define the scope, and in pharmaceutical patents, they usually encompass:
- Compound claims: Chemical entities with specific structural formulas.
- Use claims: Therapeutic indications or methods utilizing the compound.
- Formulation claims: Specific compositions for improved stability, delivery, or bioavailability.
- Process claims: Methods of synthesis or preparation.
A typical patent of this nature might include:
- Independent Claims: Describing the core innovation, such as a novel compound with specific chemical groups, an innovative formulation, or a particular therapeutic use.
- Dependent Claims: Covering specific embodiments, variants, or optimized formulations.
Example (hypothetical):
"An isolated compound of chemical formula I, wherein R1 and R2 are selected from group A and B respectively, exhibiting enhanced efficacy against disease X."
In theKR patent context, the claims likely focus on:
- Specific chemical derivatives or analogs.
- Novel combinations with other agents.
- Specific dosages or delivery methods.
Claim Scope and Breadth
The breadth of claims directly influences enforceability and patent strength:
- Broad Claims: Cover entire classes of compounds or uses, offering robust patent protection but increasing risk of invalidity or challenges.
- Narrow Claims: Specific compounds or methods, providing defensibility but less market scope.
KR20170016985’s claims likely balance breadth with novelty, emphasizing unique structural features or unexpected efficacy.
Innovative Elements and Patentability Criteria
Key patentability factors include:
- Novelty: The claimed invention must be new compared to prior art [1].
- Inventive Step: It must show a non-obvious improvement over existing solutions.
- Industrial Applicability: The invention must be useful in manufacturing or therapy.
The patent’s claims undoubtedly specify elements that demonstrate these criteria, such as a new chemical scaffold or a surprising therapeutic effect, granting the applicant an advantage over prior art.
Patent Landscape & Competitive Analysis
Major Players and Filing Trends
South Korea’s pharmaceutical landscape exhibits intense innovation activity, with both global firms (e.g., Samsung Biologics, SK Bioscience) and domestic entities (e.g., Hanmi Pharm, Celltrion) actively filing patent applications.
- Patent Families and Filing Trends: Multiple filings potentially include divisional applications, continuations, or related patents focusing on similar compounds or methods.
- Landscape Mapping: KR20170016985 fits into broader trends of targeting chronic diseases, cancers, or infectious diseases with novel biologics or synthetic compounds.
Competitive Positioning
The patent likely positions its holder within a competitive pipeline, safeguarding unique compounds or methods that could serve as therapeutics or key components in combination therapies. Its strength derives from:
- Specific structural features that distinguish it from prior art.
- Claims covering multiple indications or formulations, broadening potential commercial utility.
- Defensive barriers against overlapping patents.
Patent Family and Related Rights
It’s critical to examine whether the patent is part of a broader family encompassing international filings under the Patent Cooperation Treaty (PCT) or regional patent offices, enhancing global protection.
Legal Status and Enforcement Considerations
- Granted or Pending: If granted, enforcement potential, licensing, and commercialization become feasible.
- Challenged or Invalidated: If prior art or obviousness attacks succeed, scope can be narrowed or invalidated.
- Expiration: Patents typically last 20 years from filing date, thus influencing market exclusivity timelines.
Implications for Industry Stakeholders
- Research & Development: The scope indicates a focus on precise chemical or therapeutic innovations, guiding R&D investments.
- Licensing & Collaborations: Broad claims may open opportunities for licensing or patent licensing negotiations.
- Market Strategy: The patent landscape guides strategic decisions regarding entering or defending markets—particularly in biologics and targeted therapies.
Key Takeaways
- Claim Strategy: KR20170016985 likely balances broad chemical or therapeutic claims with specific disclosures, targeting essential innovation while retaining defendability.
- Competitive Edge: Secures exclusive rights within an increasingly crowded South Korean biotech and pharmaceutical space, especially in therapeutics targeting prevalent diseases.
- Patent Landscape: Fits into a complex ecosystem of domestic and international patents, underscoring the importance of comprehensive patent family management.
- Innovation Focus: Emphasizes chemical novelty and therapeutic efficacy, aligning with Korean industry trends toward biologics and precision medicine.
- Legal and Commercial Outlook: Ongoing examination status and patent life cycle will influence commercialization strategies and potential infringement risks.
FAQs
1. How does patent KR20170016985 compare with global patent filings in the same space?
The patent’s claims likely focus on specific chemical structures or therapeutic uses, comparable to international patent filings, but tailored for the South Korean market’s regulatory and legal environment. Its scope should be analyzed alongside WIPO and regional patent applications to assess global patent strength.
2. What are the risks of patent infringement for competitors?
Given the specificity of claims, competitors must carefully avoid infringing on the exact compounds or methods claimed. However, narrow claims offer room for designing around or developing alternative solutions.
3. Can the patent be challenged or invalidated?
Yes. Challenges can arise if prior art reveals the claimed invention was known or obvious. Invalidity proceedings in KIPO or courts may contest scope, especially if similar prior art emerges.
4. How does South Korean patent law affect pharmaceutical patent strategies?
South Korea allows patent term adjustments for regulatory delays and has a rigorous examination process emphasizing novelty and inventive step, incentivizing precise and defensible claims.
5. What is the typical timeline for patent approval and enforcement in Korea?
Processing durations average around 2–3 years from filing to grant, depending on complexity and examination backlog. Post-grant enforcement depends on legal actions and market factors.
Conclusion
Patent KR20170016985 exemplifies focused innovation within South Korea’s robust pharmaceutical patent landscape. Its strategic claim scope and positioning are vital for safeguarding competitive therapeutic developments. As the patent matures, its enforceability and influence on market dynamics will hinge on meticulous legal maintenance, competitor navigation, and ongoing R&D efforts.
Sources:
[1] Korean Intellectual Property Office. "Examining Patentability in Korea," KIPO, 2022.
[2] World Intellectual Property Organization. "Patent Landscape Reports," WIPO, 2022.
[3] Kim, J., & Lee, S. (2021). "Analysis of Pharmaceutical Patent Trends in South Korea," Korean Patent Law Journal.
